Treatment response as surrogate to predict risk for disease progression in pediatric medulloblastoma with persistent magnetic resonance imaging lesions after first-line treatment
Denise Obrecht(Universität Hamburg), Stefan Rutkowski(Universität Hamburg), Martin Benesch(St Nicholas Hospital), Dominik Sturm(German Cancer Research Center), Brigitte Bison(University of Augsburg), Gudrun Fleischhack(Essen University Hospital), Nicolas U. Gerber(University Children's Hospital Zurich), Stefan M. Pfister(Heidelberg University), Torsten Pietsch(University Hospital Bonn), Rolf‐Dieter Kortmann(University of Turin), Felix Sahm(German Cancer Research Center), Ulrich Schüller(Universität Hamburg), Martin Mynarek(Universität Hamburg), Gunther Nussbaumer(Medical University of Graz), Martin Sill(German Cancer Research Center), Lena Schömig(Universität Hamburg), Rudolf Schwarz(Universität Hamburg), André O. von Bueren(University of Geneva)
Cited by 1
Related Papers
Adjuvant Whole-Brain Radiotherapy Versus Observation After Radiosurgery or Surgical Resection of One to Three Cerebral Metastases: Results of the EORTC 22952-26001 Study
|Journal of Clinical Oncology|2010|2k
Medulloblastoma Comprises Four Distinct Molecular Variants
|Journal of Clinical Oncology|2010|1.4k
EXTENT OF RESECTION AND SURVIVAL IN GLIOBLASTOMA MULTIFORME
|Neurosurgery|2008|1k